SIGI
NVO

Susquehanna International Group (Ireland)’s Novo Nordisk NVO Stock Holding History

Susquehanna International Group (Ireland)’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,502
Closed -$578K – 105
2024
Q1 		$578K Buy
+4,502
New +$536K 0.14% 55
2023
Q4 		– Sell
-26,027
Closed -$2.37M – 81
2023
Q3 		$2.37M Buy
26,027
+1,535
+6% +$135K 0.56% 15
2023
Q2 		$1.98M Buy
+24,492
New +$2M 1.6% 13
2019
Q2 		– Sell
-67,532
Closed -$1.77M – 33
2019
Q1 		$1.77M Hold
67,532
– – 4.23% 9
2018
Q4 		$1.56M Buy
+67,532
New +$1.5M 1.31% 18

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Susquehanna International Group (Ireland)'s NVO Position: Q2 2024 in Review

Susquehanna International Group (Ireland) sold out of Novo Nordisk (NVO) in Q2 2024, closing a stake of 4,502 shares — an estimated $578K sold.

Susquehanna International Group (Ireland) first reported a position in NVO in Q4 2018 and held it in 5 quarters. The position peaked at $2.37M in Q3 2023. 1,864 funds tracked by Wall St. Rank hold NVO as of Q2 2024.

  • Susquehanna International Group (Ireland) reported no remaining Novo Nordisk position as of Q2 2024 after selling out during the quarter.
  • Susquehanna International Group (Ireland) sold 4,502 Novo Nordisk shares in Q2 2024, an estimated $578K.
  • Susquehanna International Group (Ireland) first reported a position in Novo Nordisk in Q4 2018 and held it in 5 quarters.
  • Susquehanna International Group (Ireland)'s Novo Nordisk position peaked at $2.37M in Q3 2023.
  • 1,864 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2024.

Based on Susquehanna International Group (Ireland)'s 13F filing for Q2 2024, filed 15 Aug 2024.